发明名称 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
摘要 Disclosed are novel compounds of the formula: and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula IA.
申请公布号 US7691856(B2) 申请公布日期 2010.04.06
申请号 US20070651128 申请日期 2007.01.09
申请人 SCHERING CORPORATION;PHARMACOPEIA, INC. 发明人 TAVERAS ARTHUR G.;CHAO JIANHUA;BIJU PURAKKATTLE J.;YU YOUNONG;AKI CYNTHIA J.;MERRITT J. ROBERT;LI GE;BALDWIN JOHN J.;LAI GAIFA;WU MINGLANG;HECKER EVAN A.
分类号 A61K31/496;A61K31/433;A61K31/4439;A61K31/4453;A61K31/5355;C07D285/06;C07D285/10;C07D417/02;C07D417/12;C07D417/14 主分类号 A61K31/496
代理机构 代理人
主权项
地址
您可能感兴趣的专利